Company Filing History:
Years Active: 2022
Title: Min Seok Yoon: Innovator in Pharmaceutical Compositions
Introduction
Min Seok Yoon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating sleep disorders. His innovative work focuses on utilizing phloroglucinol as an active ingredient to enhance sleep quality and mitigate side effects associated with conventional treatments.
Latest Patents
Min Seok Yoon holds 1 patent related to his research. The patent describes compositions for ameliorating, preventing, or treating somnipathy, which includes phloroglucinol as an active ingredient. Additionally, it covers compositions designed to suppress intolerance to or alleviate side effects of agonists at the benzodiazepine binding site of the GABA-A receptor. This invention is particularly noteworthy as it aims to provide a pharmaceutical composition and a health functional food composition that can effectively induce and maintain sleep without causing residual sedative effects.
Career Highlights
Min Seok Yoon is affiliated with the Korea Food Research Institute, where he continues to advance his research in the field of health and nutrition. His work is characterized by a commitment to improving the quality of life for individuals suffering from sleep disorders. He has developed formulations that not only enhance sleep but also ensure that users do not experience adverse effects commonly associated with long-term use of traditional sleep medications.
Collaborations
Min Seok Yoon collaborates with esteemed colleagues such as Sueng Mok Cho and Min Young Um. Their combined expertise contributes to the innovative research and development efforts at the Korea Food Research Institute.
Conclusion
Min Seok Yoon's contributions to the field of pharmaceuticals, particularly in the area of sleep disorder treatments, highlight his role as a leading inventor. His innovative use of phloroglucinol in compositions for ameliorating somnipathy represents a significant advancement in the quest for effective and safe sleep aids.